Cargando…

High vaccine effectiveness against coronavirus disease 2019 (COVID-19) and severe disease among residents and staff of long-term care facilities in Norway, November 2020–June 2021

Coronavirus disease 2019 (COVID-19) causes high morbidity and mortality in long-term care facilities (LTCFs). COVID-19 vaccine effectiveness against infection was 81.5% and 81.4% among fully vaccinated residents and staff in LTCFs. The vaccine effectiveness against COVID-19-associated death was 93.1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starrfelt, Jostein, Danielsen, Anders Skyrud, Kacelnik, Oliver, Wang Børseth, Anita, Seppälä, Elina, Meijerink, Hinta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Concise Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615003/ https://www.ncbi.nlm.nih.gov/pubmed/36310780 http://dx.doi.org/10.1017/ash.2021.246

Ejemplares similares

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021
por: Starrfelt, Jostein, et al.
Publicado: (2022)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

Birthing parents had a lower risk of testing positive for SARS-CoV-2 in the peripartum period in Norway, 15(th) of February 2020 to 15(th) of May 2021
por: Danielsen, Anders Skyrud, et al.
Publicado: (2021)

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021
por: Luke, Jessie, et al.
Publicado: (2022)

Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022
por: Kislaya, Irina, et al.
Publicado: (2023)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study
por: Andersson, Niklas Worm, et al.
Publicado: (2023)

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
por: Veneti, Lamprini, et al.
Publicado: (2022)

Association between job role and coronavirus disease 2019 (COVID-19) among healthcare personnel, Iowa, 2021
por: Kobayashi, Takaaki, et al.
Publicado: (2022)

Targeting TB or MRSA in Norwegian municipalities during ‘the refugee crisis’ of 2015: a framework for priority setting in screening
por: Danielsen, Anders Skyrud, et al.
Publicado: (2019)

Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021
por: Nickel, Katelin B., et al.
Publicado: (2022)

Contemporary Concise Review 2021: Interstitial lung disease
por: McCarthy, Cormac, et al.
Publicado: (2022)

The value of Facebook in nation-wide hospital quality assessment: a national mixed-methods study in Norway
por: Bjertnaes, Oyvind, et al.
Publicado: (2020)

Changes in infection control practice for coronavirus disease 2019 (COVID-19) between 2020 and 2021: A nationwide questionnaire survey in Japan
por: Honda, Hitoshi, et al.
Publicado: (2021)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

A survey of preparedness against coronavirus disease 2019 (COVID-19) in hospitals in Tokyo, Japan, with healthcare personnel with COVID-19 and in-facility transmission
por: Tagashira, Yasuaki, et al.
Publicado: (2020)

Resurgence of human coronavirus OC43 at a long-term care facility during the coronavirus disease 2019 (COVID-19) pandemic: Outbreak investigation
por: Ohyama, Koji, et al.
Publicado: (2023)

The role of the social vulnerability index in personal protective equipment shortages, number of cases, and associated mortality during the coronavirus disease 2019 (COVID-19) pandemic in Michigan skilled nursing facilities
por: LeRose, Jennifer J., et al.
Publicado: (2020)

Not as simple as it seems: extensive facility and training gaps in nursing home bathing
por: Nguyen, Kristine P., et al.
Publicado: (2023)

After the elections of the new Staff Council, the Staff Association Assizes on 29 and 30 November 2021
por: Staff Association
Publicado: (2021)

Role of diagnostic stewardship in reducing healthcare-facility–onset Clostridioides difficile infections
por: Shallal, Anita B., et al.
Publicado: (2023)

Antibiotic prescribing knowledge: A brief survey of providers and staff at an ambulatory cancer center during Antibiotic Awareness Week 2019
por: Gulleen, Elizabeth A., et al.
Publicado: (2022)

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
por: Giddings, Rebecca, et al.
Publicado: (2021)

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Practices and activities among healthcare personnel with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection working in different healthcare settings—ten Emerging Infections Program sites, April–November 2020
por: Chea, Nora, et al.
Publicado: (2022)

Monkeypox transmission following exposure in healthcare facilities in nonendemic settings: Low risk but limited literature
por: Zachary, Kimon C., et al.
Publicado: (2022)

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
por: Brandal, Lin T., et al.
Publicado: (2021)

HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks
por: Prins, Henrieke A.B., et al.
Publicado: (2023)

Infection prevention and antibiotic stewardship program needs and practices in 2021: A survey of the Society for Healthcare Epidemiology of America Research Network
por: Coffey, KC, et al.
Publicado: (2023)

Reducing the number of catheter-associated urinary tract infections at an inpatient rehabilitation facility: A quality improvement project
por: Walker, Clayton R., et al.
Publicado: (2023)

Dowling-Degos Disease - A Novel Presentation of An Uncommon Disease
por: Mohanty, Prasenjeet, et al.
Publicado: (2019)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Influence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccinations on cluster events among patients and staff in a tertiary-care hospital in Germany
por: Eisenmann, Michael, et al.
Publicado: (2022)

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018
por: Kazakova, Sophia V., et al.
Publicado: (2022)

Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable models
por: Danielsen, Anders Skyrud, et al.
Publicado: (2023)

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021
por: Graciaa, Daniel S., et al.
Publicado: (2022)

Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
por: Meijerink, Hinta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l2pterrtcbfn9qt3stho7dpk6c